# XDEMVY
> **NDA217603** · New Drug Application · Sponsor: TARSUS · Approved 2023-07-24
## Drug
- **FDA Application Number:** NDA217603
- **Application type:** New Drug Application
- **Brand name:** XDEMVY
- **Generic name:** LOTILANER OPHTHALMIC SOLUTION
- **Active ingredients:** LOTILANER
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** TARSUS
- **Manufacturer:** Tarsus Pharmaceuticals, Inc.
- **First approval:** 2023-07-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217603)
---
*AI Analytics · CC0 1.0*